| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 9 | |
| #2 | Australia | 6 | |
| #3 | United Kingdom | 4 | |
| #4 | WIPO (World Intellectual Property Organization) | 4 | |
| #5 | Canada | 3 | |
| #6 | United States | 3 | |
| #7 | China | 2 | |
| #8 | Japan | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Brotchie Jonathan | 25 |
| #2 | Hill Michael | 19 |
| #3 | Crossman Alan | 15 |
| #4 | Silverdale Montague | 5 |
| #5 | Jonathan Brotchie | 2 |
| #6 | Kottke Tim | 2 |
| #7 | Saur Oliver | 2 |
| #8 | Sasse Britta Caroline | 2 |
| #9 | Hill Michael Peter | 2 |
| #10 | Alan Crossman | 2 |
| Publication | Filing date | Title |
|---|---|---|
| GB0721333D0 | Medicaments | |
| GB0721332D0 | Medicaments | |
| CN1681512A | Use of 2,3-benzodiazepines in preparing medicine for treatment of basal ganglia-related movement disorders | |
| CN1681491A | Treatment of dyskinesia | |
| EP1815854A1 | Treatment of dyskenesia | |
| GB0307824D0 | Treatment of dyskinesia | |
| GB0304227D0 | Treatment of basal ganglia-related movement disorders |